Due to the extensive variability in the type, quality, and consistency of the articles available, a meta-analysis was not able to be conducted as this study was not able to adjust for the level of heterogenicity
And I think people need to-- if they're monitoring their cells, fine
doi: 10.3389/fpsyt.2025.1569826 Received 01 February 2025 Accepted 16 July 2025 Published 19 August 2025 Volume 16 - 2025 Edited by Sandra Moreno, Roma Tre University, Italy Reviewed by Poonam Chanderlal Sharma, University of Mississippi Medical Center, United States Ashish Patil, Roche, United States Updates Copyright 2025 Han, Almeida, Anand, Salloum, Kanaan, Gadad and Daher
Canakinumab, an interleukin-1 inhibitor, in patients with prior MI and elevated CRP, provided strong evidence for a significant reduction in the risk of recurrent MI, stroke, and cardiovascular death (Ridker et al., 2017)
Muscle mass begins to decline after early middle age and many people will lose a substantial percentage of their quadriceps muscles, the ones that are essential for rising from a sitting position